← Back to feed

BSF Enterprise

BSFA · Main Market · Health Care · mcap £2.4m today

All announcements

All RNS · 41 Key events · 35

23 Sep 26

Key US patent for ETSYL Technology

BSF Enterprise Plc (LSE: BSFA), (OTCQB: BSFAF), the biotechnology company focused on developing tissue engineering, lab-grown materials, and bioactive solutions, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a...
RNS 9785592 ↗
25 Aug 26

Conversion of Convertible Loan Notes

BSF Enterprise Plc (LSE: BSFA), (OTCQB: BSFAF), the biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, announces that it has received a notice from Indigo Capital Investments ("Indigo") to convert £100,283 of...
RNS 9737673 ↗
17 Aug 26

LGL Ultra-Lux Automotive & Advanced Robotics Skin

Lab-Grown Leather for Ultra-Luxury Automotive & Advanced Robotics Skin
RNS 9723847 ↗
11 Aug 26

Worldwide Commercialisation of ETSYL

Worldwide Exclusive Commercialisation of ETSYL® in Luxury Cosmetics & Skincare
RNS 9714331 ↗
03 Aug 26

Heads of Terms - US Joint Venture

Heads of Terms Executed for US Joint Venture
RNS 9699685 ↗
30 Jun 26

Interim 2026 Results

BSF (LSE: BSFA), (OTCQB: BSFAF), a leading innovator in tissue-engineered materials is pleased to announce its unaudited interim results for the six months ending 31 March 2026.
RNS 9642923 ↗
26 Jun 26

BSF Wins Cannes 2026 Awards for T-Rex Leather

BSF Subsidiary Wins Major Accolades at Cannes Lions 2026 for T-Rex Leather™
RNS 9637904 ↗
16 Jun 26

Auction Operational Update & Strategic Progress

Paris Auction Operational Update & Platform Strategic Progress
RNS 9619502 ↗
12 Jun 26

Paris Auction Result

BSF Enterprise Plc ("BSF" or the "Company"), an investor in next-generation bio-sustainable technologies , provides an update following the Tentation°4 sale managed by Giquello SAS at the Hôtel Drouot auction house in Paris yesterday evening, Thursday 11 June.
RNS 9614688 ↗
11 Jun 26

£1 Million Convertible Loan Note

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has entered into an interest-free Convertible Loan Note Instrument (the "CLN") with Indigo Capital LP ("Indigo")...
RNS 9612331 ↗
08 Jun 26

Shareholder meeting results

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed by shareholders by way...
RNS 9606984 ↗
03 Jun 26

Conditional Further Investment

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 25,000,000 new ordinary shares in the Company ("Placing Shares") raising £500,000 before...
RNS 9598390 ↗
02 Jun 26

Technical White Paper on T-Rex Leather™

Publication of Technical White Paper on T-Rex Leather™
RNS 9597036 ↗
28 May 26

Auction Update - May 2026

BSF Enterprise PLC ("BSF" or the "Company"), a biotech platform company driving a bio-sustainable future, announces updates to the planned auction of Lab-Grown Leather Ltd (BSF's wholly owned subsidiary) unique T-rex leather handbag.
RNS 9588640 ↗
26 May 26

Strategic Update May 2026

BSF Enterprise PLC ("BSF" or the "Company"), a biotech platform company driving a bio-sustainable future through its three high-growth subsidiaries, announces updates to its strategic operations for 1/2-year 2026.
RNS 9583871 ↗
05 May 26

T-Rex Leather™ handbag to be auctioned

A Historic Milestone in Luxury and Biotechnology -
RNS 9550712 ↗
17 Apr 26

Admission of Shares

Further to the announcement published on 02 April 2026, BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, announces that 38,500,000 ordinary shares of £0.01 each in the issued share capital of the Company...
RNS 9525984 ↗
13 Apr 26

Strategic Shareholding Update

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce, further to the Company's announcement of 2 April 2026 regarding the placing of new ordinary shares (the "Placing"), that Mr...
RNS 9515660 ↗
07 Apr 26

World’s First T-Rex Leather Handbag Unveiled

BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of tissue engineering and sustainable biotechnology, is pleased to announce the successful unveiling of the world's first handbag made from cultivated T-Rex Leather™ via its wholly owned...
RNS 9506985 ↗
02 Apr 26

Further Investment and Appointment of Adviser

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has placed 38,500,000 new ordinary shares in the Company ("Placing Shares") raising £385,000 before expenses at 1p...
RNS 9506316 ↗
02 Apr 26

World First T-Rex Leather™ Product

BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of lab-grown tissues and sustainable biotechnology, is pleased to announce the unveiling of the world's first product made from lab-grown T-Rex Leather™ via its wholly owned subsidiary...
RNS 9504424 ↗
19 Mar 26

Supply Agreement with SeaWith

BSF Enterprise PLC (LSE: BSFA) (the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that its subsidiary, 3D Bio-Tissues Limited ("3DBT"), has entered into a five-year commercial Supply Agreement (the "Agreement") with...
RNS 9481363 ↗
17 Mar 26

LGL Tanning Milestones

BSF Enterprise PLC (LSE: BSFA), the tissue-engineering innovator, is pleased to report a major technical and commercial milestone for its wholly-owned subsidiary, Lab-Grown Leather Ltd ("LGL").
RNS 9476927 ↗
13 Mar 26

Further Update on Fundraise & Reorganisation

Further Update on Proposed £15m Equity Fundraise and Capital Reorganisation
RNS 9472515 ↗
10 Mar 26

First Tannable A4-Sized Skin Achieved

Scalable Process Unlocked for Elemental™; T-Rex Leather™ Showcase Confirmed for 2 April 2026
RNS 9467272 ↗
27 Feb 26

Update on Proposed Equity Fundraise

Update on Proposed Equity Fundraise and Capital Reorganisation
RNS 9449929 ↗
09 Feb 26

Notice of AGM

BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue engineered materials, is pleased to announce The Notice of the Annual General Meeting (to be held at 10a.m.
RNS 9420113 ↗
03 Feb 26

Annual Financial Report - Correction

BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials, advises in relation to its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025 released yesterday, that there is a correction to the...
RNS 9406030 ↗
02 Feb 26

Annual Report

BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials, is pleased to announce that its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025 have been published.
RNS 9399812 ↗
19 Jan 26

Kerato Limited Signs With Quebec Pso Grant

KERATO LIMITED SIGNS WITH QUEBEC PSO GRANT TO SUPPORT VETERINARY TRIALS AND ACCELERATE NORTH AMERICAN MARKET ENTRY
RNS 9364031 ↗
16 Dec 25

3D Bio-Tissues Signs Supply Agreement with SeaWith

3D Bio-Tissues Limited Signs Commercial Supply Agreement with SeaWith
RNS 9298698 ↗
15 Dec 25

Changes to timetable for proposed Equity Fundraise

Changes to timetable for proposed Equity Fundraise and Capital Reorganisation
RNS 9295792 ↗
05 Dec 25

BSF Enterprise launches new Investor website

BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue engineered materials, is pleased to announce the launch of our interactive investor website.
RNS 9278512 ↗
01 Dec 25

Proposed Equity Fundraise - Strategic Direction

BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials ("BSF" or the "Company"), is pleased to provide further information on the expected strategic direction from the proceeds of its proposed £15 million equity fundraise, the...
RNS 9266215 ↗
01 Dec 25

Equity Fundraise & Notice of General Meeting

Convertible Loan, Proposed Equity Fundraise and Capital Reorganisation
RNS 9265959 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.